Skip to main content
. 2021 Aug 18;11:720701. doi: 10.3389/fcimb.2021.720701

Figure 1.

Figure 1

(A) Prevalence of ESBL-EC from different clinical specimens; Protected specimen brush (PSB). (B) Evolution of urinary tract infections due to ESBL-EC (Male, Female and Total) per year (from 2016 to 2019). (C) Age distribution of the affected patients with ESBL-EC (Male/Female) in the outpatient and inpatient groups.